US 10995061
SPAK kinase inhibitors as neuroprotective agents
granted A61PA61P25/28A61P9/10
Quick answer
US patent 10995061 (SPAK kinase inhibitors as neuroprotective agents) held by United States Government as represented by the Department of Veterans Affairs expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/28, A61P9/10